Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) The following represents disclosure information provided by authors ...

Kaposi's sarcoma (KS) is a low-grade vascular neoplasm mediated by the human herpesvirus-8. Only 1 clinical subtype, the endemic/African subtype, commonly affects the pediatric population. Although ...

DelveInsight’s “Kaposi’s Sarcoma Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as ...

Patients with HIV-negative Kaposi sarcoma (KS) can be successfully treated with immunotherapy even if they also have psoriasis or other skin conditions, according to a new case report. The paper ...

Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...

The US Food and Drug Administration (FDA) has granted accelerated approval to pomalidomide (Pomalyst, Bristol-Myers Squibb) for the treatment of AIDS-related Kaposi sarcoma that is resistant to highly ...

G-doctor with older man In this case series, all 9 affected patients were Black or Hispanic. Post-transplant Kaposi sarcoma, while rare, appears to occur more often in minorities, according to a ...

Viruses are masters of stealth, often lurking silently in our bodies. For the Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), the human mouth serves as an ...

The "Kaposi Sarcoma - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Kaposi Sarcoma was estimated at US$162.3 Million in 2023 and ...